The N-terminal domain of 2',3'-cyclic nucleotide 3'-phosphodiesterase harbors a GTP/ATP binding site

Chem Biol Drug Des. 2007 Dec;70(6):502-10. doi: 10.1111/j.1747-0285.2007.00592.x. Epub 2007 Nov 6.

Abstract

The interaction between 2',3'-cyclic nucleotide 3'-phosphodiesterase and guanine/adenine nucleotides was investigated. The binding of purine nucleotides to 2',3'-cyclic nucleotide 3'-phosphodiesterase was revealed by both direct and indirect methods. In fact, surface plasmon resonance experiments, triphosphatase activity measurements, and fluorescence experiments revealed that 2',3'-cyclic nucleotide 3'-phosphodiesterase binds purine nucleotide triphosphates with an affinity higher than that displayed for diphosphates; on the contrary, the affinity for both purine monophosphates and pyrimidine nucleotides was negligible. An interpretation of biological experimental data was achieved by a building of 2',3'-cyclic nucleotide 3'-phosphodiesterase N-terminal molecular model. The structural elements responsible for nucleotide binding were identified and potential complexes between the N-terminal domain of CNP-ase and nucleotide were analyzed by docking simulations. Therefore, our findings suggest new functional and structural property of the N-terminal domain of CNPase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2',3'-Cyclic-Nucleotide Phosphodiesterases / chemistry*
  • 2',3'-Cyclic-Nucleotide Phosphodiesterases / metabolism
  • Animals
  • Binding Sites / physiology
  • Computer Simulation*
  • Models, Molecular*
  • Protein Binding / physiology
  • Purine Nucleotides / chemistry*
  • Purine Nucleotides / metabolism
  • Rats
  • Structure-Activity Relationship
  • Substrate Specificity / physiology

Substances

  • Purine Nucleotides
  • 2',3'-Cyclic-Nucleotide Phosphodiesterases